Perla Giles, a rising senior majoring in molecular microbiology, and David Lee, a rising senior majoring in chemistry, both ...

Stanford researchers have developed a technology that delivers RNA to damaged neurons and stimulates regrowth – paving the ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond ...

“This open IND for HG202 by the U.S. FDA — the first regulator to have cleared CRISPR/Cas13 for clinical development — represents an important milestone for HuidaGene and the entire CRISPR ...

RNA-targeting tools like CRISPR/Cas13 are powerful but inefficient in the cytoplasm of cells, where many RNA viruses replicate. Scientists have devised a solution: Cas13d-NCS. This new molecular ...

Through transcript-specific mechanisms that are independent of the CRISPR RNA sequence and dynamically dependent on the conformational state of Cas13, Cas13 can also cleave host RNA. This effect ...

Their research shows that the CRISPR-Cas13 editor delivered by adeno-associated virus (AAV) can directly target and eliminate RNA viruses in laboratory models. AAV are delivery vehicles derived ...

BOSTON--(BUSINESS WIRE)--Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the closure of a seed round of funding, led by Khosla ...

The Cas13 protein uses a short segment of RNA to guide itself to mRNA, where it cuts and destroys the mRNA in a sequence-specific fashion. The aim of CRISPR/Cas13 is to destroy these respiratory ...